We are live on ! Find out more
BSTC

BioSpecifics Technologies Corp.
BSTC

Delisted

BSTC was delisted on the 1st of December, 2020.

Back to rankings

85 hedge funds and large institutions have $109M invested in BioSpecifics Technologies Corp. in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 15 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

425% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 4

160% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 15

39% more capital invested

Capital invested by funds: $78.6M → $109M (+$30.6M)

25% more funds holding

Funds holding: 68 → 85 (+17)

Holders
85
Holders Change
+17
Holders Change %
+25%
% of All Funds
2.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
39
Reduced
15
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NI
Numeric Investors
Massachusetts
+$2.57M
2
ECP
Elk Creek Partners
Colorado
+$2.44M
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.31M
4
PNC Financial Services Group
PNC Financial Services Group
Pennsylvania
+$1.64M
5
RFC
Russell Frank Company
Washington
+$1.64M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$5.96M
2
RA
Royce & Associates
New York
-$1.45M
3
MCM
McKinley Capital Management
Alaska
-$1.19M
4
DCM
DAFNA Capital Management
California
-$1.01M
5
Franklin Resources
Franklin Resources
California
-$683K
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
76
Tower Research Capital (TRC)
New York
$6K +$3.24K +85 +137%
CCS
77
Crosspoint Capital Strategies
California
$5K +$4.5K +118 New
MTIP
78
Magee Thomson Investment Partners
California
$5K +$4.77K +125 New
Federated Hermes
79
Federated Hermes
Pennsylvania
$4K -$7.29K -191 -62%
Deutsche Bank
80
Deutsche Bank
Germany
$2K +$725 +19 +53%
SEI Investments
81
SEI Investments
Pennsylvania
$2K +$2.14K +56 New
Royal Bank of Canada
82
Royal Bank of Canada
Ontario, Canada
$1K +$1.22K +32 New
BRWA
83
B. Riley Wealth Advisors
Florida
$71 +$69.7K +1,827 New
Manulife (Manufacturers Life Insurance)
84
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$62 +$16.6K +434 +37%
DM
85
Deerfield Management
New York
– -$5.96M -168,883 Closed
MCM
86
McKinley Capital Management
Alaska
– -$1.19M -33,615 Closed
Calamos Advisors
87
Calamos Advisors
Illinois
– -$334K -9,456 Closed
BNP Paribas Financial Markets
88
BNP Paribas Financial Markets
France
– -$4.38K -124 Closed
LTFS
89
Ladenburg Thalmann Financial Services
Florida
– +$76 +2 New
1 2 3
4

BSTC Hedge Fund Activity: Q4 2014 in Review

85 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q4 2014, worth a combined $109M — up 39% from $78.6M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new BSTC positions and 4 closed out — a net gain of 17 holders — while 39 added to existing stakes and 15 trimmed.

The largest buyer was Numeric Investors, adding an estimated $2.57M. The largest seller was Deerfield Management, exiting entirely with an estimated $5.96M sold.

  • 85 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q4 2014, up from 68 in Q3 2014.
  • Funds reported $109M of BioSpecifics Technologies Corp. stock for Q4 2014, up 39% quarter-over-quarter.
  • 21 funds opened new BioSpecifics Technologies Corp. positions in Q4 2014 and 4 closed out, a net change of +17 holders.
  • The largest BioSpecifics Technologies Corp. buyer in Q4 2014 was Numeric Investors, an estimated $2.57M added.
  • The largest BioSpecifics Technologies Corp. seller in Q4 2014 was Deerfield Management, an estimated $5.96M sold.

Based on aggregated 13F filings for Q4 2014.